openPR Logo
Press release

Workshop on Connected Devices and Digital Health: How to Navigate the U.S. FDA Usability Engineering Requirements

06-15-2021 09:04 PM CET | Health & Medicine

Press release from: SMi Group

Pre-Filled Syringes San Francisco Conference 2021

Pre-Filled Syringes San Francisco Conference 2021

SMi Reports: Workshop will include case studies related to emergent digital health innovations currently coming out of Silicon Valley, software apps connected to drug delivery platforms, and new applications for medical software.

Our conference co-chair Shannon Clark has conducted numerous workshops on human factors and usability testing throughout the world, from Stockholm to Shanghai. This year’s workshop will discuss the U.S. FDA Human Factors Engineering Process in the context of digital health and connected devices, as well as unique U.S. FDA regulatory hurdles related to this domain.

Running alongside the main conference will be an interactive post-conference workshop on September 15th, 2021 on 'Connected Devices and Digital Health: How to Navigate the U.S. FDA Usability Engineering Requirements'

Why you should attend:
• Review all applications for connected devices
• Discuss the unique U.S. FDA regulatory requirements related to phone applications
• and connected devices
• Discover common software and device development pitfalls related to connected
• devices and digital health
• Walk through the unique considerations for your human factor’s strategy and the
• details of usability testing for Apps and connected devices

Visit the event website to learn more and download the brochure at www.prefilled-sanfrancisco.com/openpr4

Key sessions discussed at workshop:

Session 1: Connected Devices and Digital Health - Current and Future Applications
• What’s the digital health landscape and latest buzz in Silicon Valley, California, as well as the rest of the world?
• What innovations are currently tackling issues of medication adherence, medical product adherence, clinical decision support, and remote patient monitoring?
• How are innovators solving patient needs via user centered design of digital health apps?

Session 2: Overview of applicable U.S. FDA usability engineering requirements & regulatory requirements for connected devices and digital health
• What U.S. FDA Regulations and Guidance do we need to know about when developing connected devices and digital health applications?
• What digital health applications are NOT governed by the U.S. FDA

Session 3: Review unique usability engineering considerations related to connected devices
• Case Study: What are some unique human factors and usability engineering considerations when developing an app and connected device?
• Case Study: What are some best practices and design considerations (i.e. heuristics) to take into account when developing digital health applications and connected devices?
• Looking Ahead: What can we expect in 2029?

Register online: www.prefilled-sanfrancisco.com/openpr4
Early bird offer register by 30th June and save $100

Sponsored by Almac| Boston Analytical | Zeon | ZwickRoell
#smipfsusa

---ENDS---

For all media inquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: hsidhu@smi-online.co.uk

India House, 45 Curlew Street

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Workshop on Connected Devices and Digital Health: How to Navigate the U.S. FDA Usability Engineering Requirements here

News-ID: 2305946 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for FDA

FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility
Peyronie’s Disease Market - Only FDA approved product
The market is dominated by a single player, Endo International plc who sells the only FDA approved Peyronie’s disease product. In May 2015, the American Urological Association presented the first ever treatment guidelines for Peyronie’s disease recommending the use of Xiaflex. Furthermore, the company is creating awareness through its “Ask About the Curve” campaign. Also, reimbursement from the U.S. insurance providers will boost the demand for this product. The product
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30). Announcing New Design Control Training Courses Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation. GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet
11-09-2016 | Science & Education
GRCTS
FDA online training
Description: Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding